SRF posted a 61% year-on-year rise in EBIT for the first quarter of fiscal year 2027, supported by growth across its chemicals and textiles segments. Following these results, Motilal Oswal has projected a 17-20% compound annual growth rate for the company through FY28. Investors should monitor how the company maintains these margins amid volatile global demand patterns.
Detailed Coverage
SRF Limited has reported a strong performance for the first quarter of fiscal year 2027, driven by recovery and expansion across its core business segments. The company saw its earnings before interest and taxes (EBIT) increase by 61% compared to the same period last year. This growth was largely supported by the chemical business, which recorded a 27% year-on-year increase in EBIT, alongside significant improvements in the technical textiles and performance films divisions. Specifically, the technical textiles segment experienced a 1.9 times rise in EBIT, while the performance films and foil business grew 1.5 times over the previous year.
Following these quarterly figures, brokerage firm Motilal Oswal has maintained a positive outlook on the stock, projecting a compound annual growth rate (CAGR) of approximately 17% for revenue, 18% for EBITDA, and 20% for adjusted profit after tax between fiscal year 2026 and 2028. The firm’s valuation model uses a sum-of-the-parts (SoTP) approach to account for the diverse nature of SRF’s operations, which span chemicals, packaging films, and technical textiles.
While the recent numbers indicate a positive trend, the company continues to operate in a complex global environment. The chemical and specialty intermediates sector has recently faced challenges related to inventory correction and pricing pressure. For investors, the sustainability of these profit margins will depend on how effectively SRF manages raw material costs and fluctuating demand in its export markets. Additionally, because the company invests heavily in capacity expansion to fuel growth, its ability to utilize new facilities efficiently without overextending its balance sheet remains an important factor.
The performance of SRF is often compared with other specialty chemical and industrial textile players. Unlike smaller peers, SRF maintains a diversified product portfolio, which can act as a buffer during downturns in a single segment. However, the company’s capital spending cycle is extensive, and investors should track the timeline for new project commissioning and any updates on debt levels in upcoming quarterly disclosures. The next key monitorable for shareholders will be management’s commentary on pricing stability and demand visibility for the remainder of the fiscal year.